Tim Friede (@tim_friede) 's Twitter Profile
Tim Friede

@tim_friede

Statistician at the University Medical Center Göttingen (UMG) Views are my own. @yourUMG @uniGoettingen

ID: 4885134083

linkhttps://medstat.umg.eu/ calendar_today07-02-2016 16:23:24

551 Tweet

592 Followers

522 Following

ENAR (@enar_ibs) 's Twitter Profile Photo

Join Drs. Chen & Ibrahim for a full-day course on Bayesian Meta-Analysis & Network Meta-Analysis. Learn flexible modeling using the R-package metapack, applied to cardiovascular disease, Crohn's disease, and other diseases. #ENAR2025 More info: buff.ly/3YTkoGz

Join Drs. Chen & Ibrahim for a full-day course on Bayesian Meta-Analysis & Network Meta-Analysis. Learn flexible modeling using the R-package metapack, applied to cardiovascular disease, Crohn's disease, and other diseases. #ENAR2025

More info: buff.ly/3YTkoGz
Gregor Andelfinger (@gregandelfinger) 's Twitter Profile Photo

Hot off the press! Excited to share our work ‘Impact of MEK Inhibition on Childhood RASopathy-Associated Hypertrophic Cardiomyopathy’ published in JACC BTS! Huge shoutout to all co-authors who stuck with us!! jacc.org/doi/epdf/10.10…

Hot off the press! Excited to share our work ‘Impact of MEK Inhibition on
Childhood RASopathy-Associated
Hypertrophic Cardiomyopathy’ published in JACC BTS!  Huge shoutout to all co-authors who stuck with us!! jacc.org/doi/epdf/10.10…
American College of Cardiology (@accintouch) 's Twitter Profile Photo

Trametinib, a mitogen-activated protein kinase inhibitor, may reduce morbidity & mortality in children w/ severe #cvHCM caused by pathogenic variants in the RAS/ mitogen-activated protein kinase signaling pathway. Read more: bit.ly/3C3Cj60 #JACCBTS #cvSurg

Trametinib, a mitogen-activated protein kinase inhibitor, may reduce morbidity & mortality in children w/ severe #cvHCM caused by pathogenic variants in the RAS/ mitogen-activated protein kinase signaling pathway.

Read more: bit.ly/3C3Cj60 #JACCBTS #cvSurg
FDA Oncology (@fdaoncology) 's Twitter Profile Photo

Save the date: April 11, 9:30am-1:30pm ET, for the 10th annual Clinical Outcome Assessment in Cancer Clinical Trials workshop: “A Decade of PROgress,” co-sponsored by the FDA Oncology Center of Excellence and the Critical Path Institute. In person at FDA White Oak or virtual.

Save the date: April 11, 9:30am-1:30pm ET, for the 10th annual Clinical Outcome Assessment in Cancer Clinical Trials workshop: “A Decade of PROgress,” co-sponsored by the FDA Oncology Center of Excellence and the Critical Path Institute. In person at FDA White Oak or virtual.
Karen Steindorf (@steindorfkaren) 's Twitter Profile Photo

A very important paper showing cost-effectiveness of the 9-month supervised EFFECT exercise intervention in mBC patients from our EU project PREFERABLE DKFZ NCT Heidelberg ascopubs.org/doi/10.1200/JC…

U.S. FDA (@us_fda) 's Twitter Profile Photo

FDA’s Rare Disease Innovation Hub has plans for 2025. Check out the Hub’s Strategic Agenda – now available online. fda.gov/industry/medic…

Gianluca Baio (@gianlubaio) 's Twitter Profile Photo

Registration open for our summer school in Bayesian methods in health economics - this year in London UCL Statistical Science 23-27 June. Details here: gianluca.statistica.it/teaching/summe… Registration is here: tinyurl.com/bmhe2025 First-come/first-serve, so hurry up!

JACC Journals (@jaccjournals) 's Twitter Profile Photo

In this #JACCBTS retrospective cohort analysis, #MEK inhibition improved transplant-free survival and reduced surgical intervention in children with #RASopathies and severe HCM. jacc.org/doi/10.1016/j.… #cvPed #cvHCM #ChildhoodCardiomyopathy Juan Pablo Kaski Gregor Andelfinger

In this #JACCBTS retrospective cohort analysis, #MEK inhibition improved transplant-free survival and reduced surgical intervention in children with #RASopathies and severe HCM. jacc.org/doi/10.1016/j.…

#cvPed #cvHCM #ChildhoodCardiomyopathy <a href="/jpkaski/">Juan Pablo Kaski</a> <a href="/GregAndelfinger/">Gregor Andelfinger</a>
Sandy Engelhardt (@sandyengelh) 's Twitter Profile Photo

We are hiring! If you are interested joining my Lab at Universitätsklinikum Heidelberg in Heidelberg as a Postdoc, reach out to me. We are working in the field of #Federated Learning, Multimodal AI and Cardiovascular Disease, eg nature.com/articles/s4174… DZHK Germany European Society of Cardiology MICCAI Students 🇪🇺 🙌

Talha Khawaja (@talhakhawaja_) 's Twitter Profile Photo

Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency - The FAIR-HF2 DZHK05 Randomized Clinical Trial Late-breaker American College of Cardiology and simultaneously published in JAMA jamanetwork.com/journals/jama/…

Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency - The FAIR-HF2 DZHK05 Randomized Clinical Trial

Late-breaker <a href="/ACCinTouch/">American College of Cardiology</a> and simultaneously published in <a href="/JAMA_current/">JAMA</a> 

jamanetwork.com/journals/jama/…
Sandy Engelhardt (@sandyengelh) 's Twitter Profile Photo

Zusammen mit der AGIK haben wir ein Simulationskonzept für die Jahrestagung auf die Beine gestellt. Es dürfen alle Kommen und Katheterinterventionelle Verfahren selbst probieren. Young DGK Young-DZHK DZHK Germany Deutsche Gesellschaft für Kardiologie

ESCAPE Project (@escapeprojecteu) 's Twitter Profile Photo

🎉 Major Milestone for ESCAPE! 🎉 ESCAPE has officially reached its recruitment target of 300 patients in our randomised trial! Now, our focus shifts to evaluation and implementation, with care managers leading the intervention phase. 🔍 Read more here: bit.ly/3FZwQyQ

Deutsche Gesellschaft für Kardiologie (@dgk_org) 's Twitter Profile Photo

#DGKJahrestagung: Frisch aus dem Vortrag – hier finden Sie die zentrale Zusammenfassung in unserer Summary Card! "Transition from Asymptomatic Systolic Chronic Heart Failure (TRANSITIONCHF)" Sprecher: A. Sandek Diskutant: R. Pfister #DGK2025JT #Kardiologie #KardiovaskuläreMedizin

#DGKJahrestagung: Frisch aus dem Vortrag – hier finden Sie die zentrale Zusammenfassung in unserer Summary Card!
"Transition from Asymptomatic Systolic Chronic Heart Failure (TRANSITIONCHF)"
Sprecher: A. Sandek
Diskutant: R. Pfister
#DGK2025JT #Kardiologie #KardiovaskuläreMedizin
ESCAPE Project (@escapeprojecteu) 's Twitter Profile Photo

💙 Interested in ESCAPE Videos? Check out our video playlist, where we break down key aspects of the project, from our innovative Blended Collaborative Care (BCC) approach to the role of care managers and digital health technologies. 📺 Watch here: bit.ly/3Edl2sa

💙 Interested in ESCAPE Videos?

Check out our video playlist, where we break down key aspects of the project, from our innovative Blended Collaborative Care (BCC) approach to the role of care managers and digital health technologies.

📺 Watch here: bit.ly/3Edl2sa
Andreas Zeiher (@andreaszeiher) 's Twitter Profile Photo

What a fantastic success 😀🍀👏 'Cardio Pulmonary Institute' for the 4th time in a row awarded 'Excellence Cluster' status by the #DFG #Exzellenzwettbewerb Thanks to all wonderful scientists contributing over 19 years 🫶 DZHK Germany Stefanie Dimmeler CPI European Research Council (ERC)

What a fantastic success 😀🍀👏
'Cardio Pulmonary Institute' for the 4th time in a row awarded 'Excellence Cluster' status by the #DFG #Exzellenzwettbewerb
Thanks to all wonderful scientists contributing over 19 years 🫶 <a href="/dzhk_germany/">DZHK Germany</a> <a href="/StefanieDimmel1/">Stefanie Dimmeler</a> <a href="/CPI_ExStra/">CPI</a> 
<a href="/ERC_Research/">European Research Council (ERC)</a>
Tim Friede (@tim_friede) 's Twitter Profile Photo

Random-effects meta-analyis of a single study? Yes, this makes sense e.g. when deriving a meta-analytic predictive (MAP) prior for the analysis of another study. In this setting there are close links to power priors and bias allowance models. arxiv.org/abs/2505.15502